Bioorganic and Medicinal Chemistry Letters

Design and synthesis of anticonvulsive agents as -vinyl GABA-based potential dual acting prodrugs and their biological activities
pp. 609-613(5)
Authors: Kim Y.Y.-c.; Zhao L.-X.L.-X.; Kim T.-H.T.-H.; Je S.S.-m.; Kim E.E.-k.; Choi H.H.; Chae W.-G.W.-G.; Park M.M.; Choi J.J.; Jahng Y.Y.; Lee E.-S.E.-S.

Synthesis of a novel class of cdc25A inhibitors from vitamin D₃
pp. 615-617(3)
Authors: Dodo K.K.; Takahashi M.M.; Yamada Y.Y.; Sugimoto Y.Y.; Hashimoto Y.Y.; Shirai R.R.

Novel retinoic acid receptor agonists: syntheses and evaluation of pyrazole derivatives
pp. 619-622(4)
Authors: Kikuchi K.K.; Hibi S.S.; Yoshimura H.H.; Tai K.K.; Hida T.T.; Tokuhara N.N.; Yamauchi T.T.; Nagai M.M.

Syntheses and evaluation of naphthalenyl- and chromenyl-pyrrolyl-benzoic acids as potent and selective retinoic acid receptor agonists
pp. 623-625(3)
Authors: Hibi S.S.; Tagami K.K.; Kikuchi K.K.; Yoshimura H.H.; Tai K.K.; Hida T.T.; Tokuhara N.N.; Yamauchi T.T.; Nagai M.M.

Yohimbine dimers exhibiting binding selectivities for human _2a- versus _2b-adrenergic receptors
pp. 627-630(4)
Authors: Zheng W.W.; Lei L.L.; Lalchandani S.S.; Sun G.G.; Feller D.R.D.R.; Miller D.D.D.D.

Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi
pp. 631-635(5)
Authors: Salmon-Chemin L.L.; Lemaire A.A.; De Freitas S.S.; Deprez B.B.; Sergheraert C.C.; Davioud-Charvet E.E.

Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts
pp. 637-639(3)
Authors: Guillou C.C.; Mary A.A.; Renko D.Z.D.Z.; Gras E.E.; Thal C.C.

Synthesis and biological evaluation of enantiopure thionitrites: The solid-phase synthesis and nitrosation of d-glutathione as a molecular probe
pp. 641-644(4)
Authors: Cavero M.M.; Hobbs A.A.; Madge D.D.; Motherwell W.B.W.B.; Selwood D.D.; Potier P.P.

Synthesis and antiviral activity of acyclovir-5'-(phenyl methoxy alaninyl) phosphate as a possible membrane-soluble nucleotide prodrug
pp. 645-647(3)
Authors: McGuigan C.C.; Slater M.J.M.J.; Parry N.R.N.R.; Perry A.A.; Harris S.S.

The solid phase synthesis of tetrahydroisoquinolines having cdc25B inhibitory activity
pp. 649-652(4)
Authors: Fritzen E.L.E.L.; Brightwell A.S.A.S.; Erickson L.A.L.A.; Romero D.L.D.L.

Diacylglycerols with lipophilically equivalent branched acyl chains display high affinity for protein kinase C (PK-C). A direct measure of the effect of constraining the glycerol backbone in DAG lactones
pp. 653-655(3)
Authors: Nacro K.K.; Bienfait B.B.; Lewin N.E.N.E.; Blumberg P.M.P.M.; Marquez V.E.V.E.

Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9
pp. 657-660(4)
Authors: Bottari B.; Maccari R.; Monforte F.; Ottana R.; Rotondo E.; Vigorita M.G.

Eryloside F, a novel penasterol disaccharide possessing potent thrombin receptor antagonist activity
pp. 661-664(4)
Authors: Stead P.P.; Hiscox S.S.; Robinson P.S.P.S.; Pike N.B.N.B.; Sidebottom P.J.P.J.; Roberts A.D.A.D.; Taylor N.L.N.L.; Wright A.E.A.E.; Pomponi S.A.S.A.; Langley D.D.

Synthesis of 19-[(2-azido-5-iodo)-benzoyloxy]-LTA₄ and enzymatic conversion to the LTC₄ analogue
pp. 665-668(4)
Authors: Vidal A.A.; Durand T.T.; Vidal J.-P.J.-P.; Rossi J.-C.J.-C.; Ravasi S.S.; Zarini S.S.; Sala A.A.

Inhibition of the ras-dependent mitogenic pathway by phosphopeptide prodrugs with antiproliferative properties
pp. 669-672(4)
Authors: Liu W.-Q.W.-Q.; Vidal M.M.; Mathe C.C.; Perigaud C.C.; Garbay C.C.

Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties
pp. 673-676(4)
Authors: Renzi G.G.; Scozzafava A.A.; Supuran C.T.C.T.

-Cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cells
pp. 677-680(4)
Authors: Schaschke N.N.; Assfalg-Machleidt I.I.; Machleidt W.W.; Laszleben T.T.; Sommerhoff C.P.C.P.; Moroder L.L.

Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X₇-receptor
pp. 681-684(4)
Authors: Baraldi P.G.P.G.; Romagnoli R.R.; Tabrizi M.A.M.A.; Falzoni S.S.; Di Virgilio F.F.